Table 2. Predictive factor of treatment failure (primary treatment failure and local tumor progression).
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| P | Hazard ratio (95%CI) | P | Hazard ratio (95%CI) | |
| Age (years) | 0.503 | 0.988 (0.955-1.022) | ||
| Sex (Male) (%) | 0.151 | 0.578 (0.273-1.218) | ||
| BMI | 0.391 | 0.968 (0.899-1.042) | ||
| Platelet count (<100G/L) | 0.517 | 1.268 (0.618-2.602) | ||
| Non-Viral hepatitis | 0.227 | 1.357 (0.827-2.228) | ||
| AFP>100 ng/ml | 0.250 | 1.605 (0.716-3.598) | ||
| HCC>3cm | 0.306 | 1.453 (0.710-2.974) | ||
| Multiple nodules | 0.542 | 1.272 (0.586-2.760) | ||
| TACE (vs RFA) | <0.001 | 5.573 (2.281 -13.62) | <0.001 | 5.573 (2.281 -13.62) |
Abbreviations: BMI= Body Mass Index; ALT= Alanine Amino Transferase; AFP= Alpha-Foeto-protein; HCC= HepatoCellular Carcinoma; RFA= Radiofrequency ablation; TACE= transarterial chemoembolization.